510(k) Report

510(k) · Cleared

Recalled · Class II · 2025

Affinity NT Oxygenator and Uncoated Cardiotomy/ Venous Reservoir (541); Affinity NT Oxygenator with Balance Biosurface and Uncoated Cardiotomy/Venous Reservoir (541B)

K241352510(k) SpecialCleared Jun 12, 202430-day reviewClass II21 CFR 870.4350Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medtronic, Inc. · DTZ Oxygenator, Cardiopulmonary Bypass

Cleared on Jun 12, 2024 as substantially equivalent to K191444 (Medtronic, Inc., 2019) after a 30-day review. Its family tree reaches back 1 generation to 2019. It has been recalled once.

Decided
Jun 12, 2024
Review
30 days
Class
Class II
Product code
DTZ
Recalls
1
Predicates
1

Its longest line of descent runs back 1 generation to K191444 (2019). No later device cites it as a predicate yet.

  1. Root · 1 generation backK191444 Affinity NT Oxygenator with Balance Biosurface, Affinity NT…Medtronic, Inc. · 2019
  2. This deviceK241352 Affinity NT Oxygenator and Uncoated Cardiotomy/ Venous Reservoir…Medtronic, Inc. · 2024
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K191444Affinity NT Oxygenator with Balance Biosurface, Affinity NT Oxygenator with…Medtronic, Inc.2019—
0 (this device)K241352Affinity NT Oxygenator and Uncoated Cardiotomy/ Venous Reservoir (541)…Medtronic, Inc.2024—
FIG. 1 — Lineage of K241352, 2019–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DTZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DTZ device

  1. #1 K240934 Quantum Perfusion Blood Oxygenator ECC…score 14.3 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K191444Affinity NT Oxygenator with Balance Biosurface, Affinity NT Oxygenator with Balance…
Summary page 5
…with Balance Biosurface and Uncoated Primary Predicate 541B Cardiotomy/Venous Reservoir K191444 NOTE: For reference, the component 1140008-503, which is the subject of this special 510(k) is cleared under K240534 for use i…
Medtronic, Inc.2019—
†K191029Affinity NTTM Oxygenator (Model 511), Affinity® NT Hollow Fiber Oxygenator with Plasma…Medtronic, Inc.2019—
†K240534Bio-Medicus Life Support Catheter and IntroducerMedtronic, Inc.2024—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Sep 12, 2025Class IIZ-0487-2026Under Investigation by firmMedtronic identified an Affinity NT Oxygenator unit with decreased CO2 gas transfer rates that did not meet performance requirements.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All DTZ devices

DTZ Oxygenator, Cardiopulmonary Bypass: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · DTZ

2in 2025

2007: 42008: 32009: 92010: 22011: 42012: 92013: 92014: 52015: 92016: 32017: 22018: 32019: 52020: 52021: 52022: 22023: 52024: 32025: 22026 (partial year): 3
2007high 9 (2009) · low 2 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DTZ

124in 2024

2007: 55 days median2008: 88 days median2009: 210 days median2011: 160 days median2012: 90 days median2013: 28 days median2014: 28 days median2015: 134 days median2016: 62 days median2018: 72 days median2019: 90 days median2020: 93 days median2021: 336 days median2023: 145 days median2024: 124 days median2026 (partial year): 137 days median
2007high 336 (2021) · low 28 (2013)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DTZ

1in 2025

2007: 72008: 52010: 12011: 132012: 142014: 22016: 12018: 2, 2 Class I2019: 12020: 32021: 1, 1 Class I2022: 62025: 1
2007high 14 (2012) · low 0 (2009)2026

Class I (3 since 2007) Class II/III not classified

Adverse event reports per year · DTZ

976in 2025

2007: 1342008: 1052009: 522010: 1192011: 1902012: 2152013: 3462014: 7642015: 6582016: 4432017: 3882018: 3202019: 4892020: 4422021: 5952022: 5592023: 7382024: 5352025: 976
2007high 976 (2025) · low 52 (2009)2025

MAUDE reports naming product code DTZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20074557134
20083885105
20099210052
20102—1119
2011416013190
201299014215
20139280346
20145282764
201591340658
20163621443
20172—0388
20183722 (2)320
20195901489
20205933442
202153361 (1)595
20222—6559
202351450738
202431240535
20252—1976
202631370—

What is it indicated for?

The AFFINITY NT Integrated CVR Membrane Oxygenator with Plasma Resistant Fiber is intended to be used in an extracorporeal perfusion circuit to collect venous and cardiotomy suctioned blood, cool or warm the blood and oxygenate and remove carbon dioxide from the blood during routine cardiopulmonary bypass procedures up to 6 hours in duration. The Affinity NT oxygenator with Balance biosurface is intended to be used in an extracorporeal perfusion circuit…

Read the full statement (131 words)

The AFFINITY NT Integrated CVR Membrane Oxygenator with Plasma Resistant Fiber is intended to be used in an extracorporeal perfusion circuit to collect venous and cardiotomy suctioned blood, cool or warm the blood and oxygenate and remove carbon dioxide from the blood during routine cardiopulmonary bypass procedures up to 6 hours in duration.

The Affinity NT oxygenator with Balance biosurface is intended to be used in an extracorporeal perfusion circuit to oxygenate and remove carbon dioxide from the blood and to cool or warm the blood during routine cardiopulmonary bypass (CPB) procedures up to 6 hours in duration. The Affinity NT cardiotomy/venous reservoir (CVR) is intended to be used in an extracorporeal perfusion circuit to collect venous and cardiotomy suctioned blood during routine CPB procedures up to 6 hours in duration.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K241352: Affinity NT Oxygenator and Uncoated Cardiotomy/ Venous Reservoir (541); Affinity NT Oxygenator with Balance Biosurface and Uncoated Cardiotomy/Venous Reservoir (541B).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K241352

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026